KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Interest Expenses (2018 - 2025)

Neogenomics' Interest Expenses history spans 12 years, with the latest figure at $599000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 63.12% year-over-year to $599000.0; the TTM value through Dec 2025 reached $3.8 million, down 43.28%, while the annual FY2025 figure was $3.8 million, 43.28% down from the prior year.
  • Interest Expenses reached $599000.0 in Q4 2025 per NEO's latest filing, down from $603000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $5.2 million in Q4 2022 to a low of $139000.0 in Q3 2022.
  • Average Interest Expenses over 5 years is $1.7 million, with a median of $1.6 million recorded in 2024.
  • Peak YoY movement for Interest Expenses: plummeted 89.27% in 2022, then surged 1112.23% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $4.8 million in 2021, then rose by 7.64% to $5.2 million in 2022, then tumbled by 67.77% to $1.7 million in 2023, then fell by 3.39% to $1.6 million in 2024, then tumbled by 63.12% to $599000.0 in 2025.
  • Per Business Quant, the three most recent readings for NEO's Interest Expenses are $599000.0 (Q4 2025), $603000.0 (Q3 2025), and $933000.0 (Q2 2025).